Hi stef2011,
Yes, I've read about replicor and other ongoing hbv drug researches; many of them are promising, but unfortunately none of them, including replicor, target the cccDNA directly. Hence if any cure, it will only be functional cure.
After searching the web, I found the following new study that is trying to use the CRISPR/Cas9 technology to directly attack the hbv cccDNA, and hence potentially eradicate the virus from the hepatocytes.
http://www.nature.com/articles/srep13734?trendmd-shared=0
you dont read our forum at all, hbv cure is replicor drug combo with peginterferon/zadaxin since years and you can see our posts years back about human trials.
no drug maker wants this approved and invest money on it, we hope replicor, very small company, will get approval in europe for hdv and so we will have a cure